secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001493152-24-043352
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics announces 1-for-50 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Effective Nov 5, 2024, at 12:01 a.m. ET; trading on split-adjusted basis from market open.
- Reverse split ratio 1-for-50; reduces shares from ~36.7M to ~737k.
- Approved by stockholders Oct 25, 2024; board set ratio same day.
- Purpose: increase bid price to regain Nasdaq minimum bid price requirement.
- Cash for fractional shares; no change in authorized shares or par value; new CUSIP 74754R 301.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224043352/0001493152-24-043352-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224043352/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-043352

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer